ArticleFrontiers in pharmacology2026

Targeting heparanase-associated epithelial glycocalyx remodeling attenuates Akt/NF-κB-related barrier dysfunction in experimental COPD.

Yueping Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.